Thirumalai Chemicals Ltd has ICRA reaffirming its [ICRA]BBB long-term ratings with a Negative outlook and [ICRA]A3+ short-term ratings
- Rated facilities include ₹445 crore in term loans, ₹334.5 crore in working-capital facilities and ₹100 crore in non-convertible debentures.
- Short-term non-fund-based facilities increased to ₹755 crore; unallocated limits fell to ₹275 crore.
- ICRA cited improved consolidated operating profitability in H1FY2027 but continued pressure on coverage indicators.
- Refinancing, liquidity and commissioning and ramp-up of the US project remain key monitorables.
